SCHEMBL1122802

SCHEMBL1122802

CCOC(=O)CN(Cc1ccc(OCc2ccccc2)cc1)C(=O)c1ccc(OCCOc2nc3ccccc3nc2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
PIN1 Q13526 1/20 0.44
LTA4H P09960 1/20 0.43
TSPO P30536 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HSP90AA1 P07900 1/20 0.43
LPAR1 Q92633 1/20 0.41
LPAR5 Q9H1C0 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
ALOX5 P09917 2/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
PTGES O14684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1122873 0.93 SLC2A1 (0.45) L3MBTL1NPC1ALDH1A1LMNAMAPT
SCHEMBL1123269 0.91 L3MBTL1 (0.50) L3MBTL1NPC1ALDH1A1LMNAMAPT
SCHEMBL1123226 0.88 L3MBTL1 (0.43) L3MBTL1NPC1LMNARAB9APIN1
SCHEMBL1123219 0.85 CYSLTR2 (0.45) L3MBTL1LTA4HMEN1KMT2AHSP90AA1
SCHEMBL1123430 0.84 PPARA (0.49) L3MBTL1PPARGPPARAALOX5PTGES
SCHEMBL1122799 0.82 L3MBTL1 (0.53) L3MBTL1NPC1ALDH1A1LMNAMAPT
SCHEMBL5720728 0.80 CYSLTR2 (0.45) L3MBTL1NPC1LMNARAB9ALTA4H
SCHEMBL1122770 0.79 SLC2A1 (0.46) L3MBTL1MEN1KMT2AHSP90AA1PPARG
SCHEMBL1122793 0.79 L3MBTL1 (0.47) L3MBTL1KMT2APPARGPPARAPTGES
SCHEMBL1123229 0.77 SLC2A1 (0.55) NPC1ALDH1A1LMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG L3MBTL1 1889/4885NPC1 3147/4885ALDH1A1 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.